JWJ. Michael Walsh

J. Michael Walsh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


J. Michael Walsh has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Ron Flegel

    The Walsh Group, PA, 6701 Democracy Blvd., Suite 300, Bethesda, MD 20817, USA

    3 shared publications
  • Dennis J. Crouch

    Utah Expert-Toxicology Services, Salt Lake City, UT

    2 shared publications
  • Leo A. Cangianelli

    The Walsh Group, PA, 6701 Democracy Blvd., Suite 300, Bethesda, MD 20817, USA

    2 shared publications
  • Randolph Atkins

    The Walsh Group, PA, 6701 Democracy Blvd., Suite 300, Bethesda, MD 20817, USA

    2 shared publications
  • Timothy J. Kerns

    Charles McC. Mathias National Study Center for Trauma and Emergency Medical Systems, University of Maryland, School of Medicine, 701 West Pratt Street, Fifth Floor, Baltimore, MD 21201, USA

    2 shared publications
  • Alain G. Verstraete

    Ghent University Hospital , Gent, Belgium

    1 shared publication

Latest Publications

  • Open Access

    Is THC-COOH a Useful Determinant for Passive Inhalation in Oral Fluid THC Testing?

    by J. Michael Walsh, Edward J. Cone, Dennis J. Crouch, Yale H. Caplan


  • Open Access

    Use of alcohol and drugs by Norwegian employees: a pilot study using questionnaires and analysis of oral fluid

    by Hallvard Gjerde, Asbjørg S Christophersen, Inger S Moan, Borghild Yttredal, J Michael Walsh, Per T Normann, Jørg Mørland

    The use of alcohol and drugs may affect workplace safety and productivity. Little is known about the magnitude of this problem in Norway.


  • Guidelines for research on drugged driving

    by J. Michael Walsh, Alain G. Verstraete, Marilyn A. Huestis, Jørg Mørland

    Aim  A major problem in assessing the true public health impact of drug‐use on driving and overall traffic safety is that the variables being measured across studies vary significantly. In studies reported in a growing global literature, basic parameters assessed, analytical techniques and drugs tested are simply not comparable due to lack of standardization in the field. These shortcomings severely limit the value of this research to add knowledge to the field. A set of standards to harmonize research findings is sorely needed. This project was initiated by several international organizations to develop guidelines for research on drugged driving.Methods  A September 2006 meeting of international experts discussed the harmonization of protocols for future research on drugged driving. The principal objective of the meeting was to develop a consensus report setting guidelines, standards, core data variables and other controls that would form the basis for future international research. A modified Delphi method was utilized to develop draft guidelines. Subsequently, these draft guidelines were posted on the internet for global review, and comments received were integrated into the final document.Results  The Guidelines Document is divided into three major sections, each focusing upon different aspects of drugged driving research (e.g. roadside surveys, prevalence studies, hospital studies, fatality and crash investigations, etc.) within the critical issue areas of ‘behavior’, ‘epidemiology’ and ‘toxicology’. The behavioral section contains 32 specific recommendations; (2) epidemiology 40 recommendations; and (3) toxicology 64 recommendations.Conclusions  It is anticipated that these guidelines will improve significantly the overall quality of drugged driving research and facilitate future cross‐study comparisons nationally and globally.


  • Drug and alcohol use among drivers admitted to a Level-1 trauma center

    by J. Michael Walsh, Ron Flegel, Randolph Atkins, Leo A. Cangianelli, Carnell Cooper, Christopher Welsh, Timothy J. Kerns


  • Drugs and Driving

    by J. Michael Walsh, Johan J. Gier, Asbjørg S. Christopherson, Alain G. Verstraete

    The authors present a global overview on the issue of drugs and driving covering four major areas: (1) Epidemiology and Prevalence—which reviews epidemiological research, summarizes available information, discusses the methodological shortcomings of extant studies, and makes recommendations for future research to better define prevalence and epidemiology; (2) Effects of Medicinal and Illegal Drugs on Driving Performance—focuses on the six classes of drugs most often found in impaired and injured drivers, draws conclusions regarding the risk of these drugs to traffic safety and discusses the need for additional research; (3) Toxicological Issues—discusses ways to identify drug users via behavioral testing and analytical techniques, reviews the approaches used by different countries, screening and confirmation techniques, alternative specimens (e.g., urine, oral fluid, sweat), and how rapid roadside testing could be coupled with behavioral and laboratory testing in an effective approach to identifying and prosecuting drugged drivers; (4) Driving Under the Influence of Drugs [DUID] Laws—provides an overview of DUID laws in the United States and Europe, discusses the basic tenets of these laws, the various types of DUID statutes, the reasons why many existing laws hinder the prosecution of drugged drivers and the rationale for developing per se legislation as a strategy to more effectively manage the drugged driver problem.


  • Epidemiology of Alcohol and Other Drug Use Among Motor Vehicle Crash Victims Admitted to a Trauma Center

    by J. Michael Walsh, Ron Flegel, Leo A. Cangianelli, Randolph Atkins, Carl A. Soderstrom, Timothy J. Kerns

    The objectives of this research were to (1) determine the incidence and prevalence of alcohol and other drug use among motor vehicle crash (MVC) victims admitted to a regional Level-I trauma center, and (2) to examine the utility of using a rapid point-of-collection (POC) drug-testing device to identify MVC patients with drug involvement. Blood and urine specimens were routinely collected per clinical protocol for each MVC victim at the time of admission. Blood alcohol concentration (BAC) levels were determined per standard clinical protocol. Clinical urine specimens were routinely split so that a POC drug-testing device for the detection of commonly abused drugs (Marijuana, Cocaine, Amphetamines, Methamphetamines, and Opiates) could be compared to that of the standard hospital laboratory analysis of each urine specimen (which also included Barbiturates and Benzodiazepines). In the six-month period of this study, nearly two-thirds of trauma center admissions were victims of motor vehicle crashes. During this time, blood and urine was collected from 322 MVC victims. Toxicology results indicated that 59.3% of MVC victims tested positive for either commonly abused drugs or alcohol. More patients tested positive for drug use than tested positive for alcohol, with 33.5% testing positive for drug use only, 15.8% testing positive for alcohol use only, and 9.9% testing positive for both drugs and alcohol. Less than half (45.2%) of the substance-abusing patients in this study would have been identified by an alcohol test alone. After alcohol, marijuana and benzodiazepines were the most frequently detected drugs. Point of collection (POC) test results correlated well with laboratory results and provide important information to initiate rapid intervention/treatment for substance use problems among injured patients.


  • Open Access

    An Evaluation of Rapid Point-of-Collection Oral Fluid Drug-Testing Devices

    by J. Michael Walsh, Ron Flegel, Dennis J. Crouch, Leo Cangianelli, Jakub Baudys

    New technology is currently being marketed to rapidly test oral fluids for drugs of abuse at the point of collection (POC). There are no nationally accepted standards or cutoff concentrations for detecting drugs in oral fluids and for most analytes there are significant differences in cutoff concentrations across devices. Four devices were evaluated (OralLab®, RapiScan, Drugwipe, and SalivaScreen®) for their ability to meet manufacturers claims, and proposed federal standards for criminal justice and workplace programs. Human oral fluid fortified with known quantities of drug [drug(s) or metabolite(s)] was used to test these devices. Overall, the performance of these rapid POC oral fluid drug-testing devices was quite variable. Some devices performed well for the analysis of some drug classes but poorly for others. In general, most devices performed well for the detection of methamphetamine and opiates, but all performed poorly for the detection of cannabinoids. The ability to accurately and reliably detect cocaine and amphetamine was dependent on the individual device.


  • Drugs in the Workplace: Research and Evaluation Data Volume II: Research Monograph 100

    by Steven W. Gust, US Department of Health and Human Services; National Institute on Drug Abuse, J. Michael Walsh, Linda B. Thomas, Dennis J. Crouch